No Carolina / NY / Florida
Ph: 561.316.3330

No Carolina | NY | Florida

THINK Surgical Announces Collaboration with Definition Health

Editor: What To Know

  • In addition, this web-based solution will incorporate Definition Health’s Total Digital Surgery platform which assists hospitals and surgeons in achieving workflow efficiency, improved perioperative care and virtual follow up for surgical patients.
  • “We are excited about this collaboration because it will enable a consistent customer experience across of all our products and provide added value options for our customers.
  • “We look forward to working with THINK and the US surgeon community to help improve care and value-based outcomes for all surgical patients.

THINK Surgical, a technology innovator developing orthopedic surgical robots, today announced a collaboration with UK based digital health company, Definition Health. The companies will jointly develop a seamless, web-based, connected care solution to enhance the surgical planning experience for surgeons using THINK’s robotic technologies for joint replacement surgery.

This web-based solution will support all of THINK’s robotic products, including new product launches planned for 2023. In addition, this web-based solution will incorporate Definition Health’s Total Digital Surgery platform which assists hospitals and surgeons in achieving workflow efficiency, improved perioperative care and virtual follow up for surgical patients.

Definition Health’s platform is widely deployed in the UK with customers reporting improved profitability for surgical service lines as well as improved patient and provider satisfaction rates. To date, over 100,000 surgical episodes have been managed by customers using this platform.

“We are excited about this collaboration because it will enable a consistent customer experience across of all our products and provide added value options for our customers.” said Stuart Simpson, chief executive officer. “We believe this platform will significantly improve surgeon and patient experience with our robotic technology.”

“We are delighted to launch our digital platform in the USA after our national recognition and success in the UK.” said Sandeep Chauhan, co-founder and chief executive officer of Definition Health. “We look forward to working with THINK and the US surgeon community to help improve care and value-based outcomes for all surgical patients.”

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Recent News

CV Societies Propel Plans Forward for a New Board of Cardiovascular Medicine

“The open comment period is the time for cardiovascular physicians, allies in other medical specialties, patients, and others to make their voices heard on why an independent CV Board is the best path for cardiologists to stay up-to-date on best practices and evidence-based care, ensuring patients receive the best possible care,” said Jeffrey Kuvin, MD, president of the proposed Board’s new Board of Directors. “The field of cardiovascular medicine has evolved dramatically over the past few decades; now is the right time to develop an independent cardiovascular Board.”

Hyundai Bioscience Announces Clinical Development Plan for Niclosamide-based Metabolic Anticancer Drug Targeting P53 Mutation Cancer

Sang-ki Oh, CEO of Hyundai Bioscience, stated, "Niclosamide-based metabolic anticancer drug candidate will be the first P53-targeting anticancer treatment that selectively kills p53 mutated cancer cells," and added, "Through our subsidiary ADM Korea, we plan to conduct clinical trials targeting cancer patients with intractable cancer caused by p53 mutations, which will be the first step of clinical development on niclosamide-based anticancer agent pipeline."

Sedana Medical Completes Patient Recruitment for INSPiRE-ICU 1 Clinical Trial in the US

Peter Sackey further elaborated: "Once the 30-day follow-up of all patients is complete, we will enter into an intense phase of final monitoring, data cleaning and transfer to our statistician team for analysis. In parallel, the long-term outcomes at 3 and 6 months will be collected centrally by the Critical Illness, Brain Dysfunction, and Survivorship team at Vanderbilt Medical Center. With this parallel approach, we expect topline results in the autumn of this year and a swift regulatory submission in Q1, 2025".

Health / Lifestyle

Articles of Interest

Stay Connected

spot_img

About Medical Device News Magazine

About Medical Device News Magazine. A digital publication founded in 2008 located in the United States. The publication is one of the industry’s leading sources of medical device and biotech industry updates. Medical Device News Magazine is easily accessible 24/7/365 and is a fast 1, 2, 3 easy read! Our purpose is...

By using this website you agree to accept Medical Device News Magazine Privacy Policy